Your browser doesn't support javascript.
loading
Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to Dasatinib.
Huang, Jie; Hu, Wei; Bottsford-Miller, Justin; Liu, Tao; Han, Hee Dong; Zand, Behrouz; Pradeep, Sunila; Roh, Ju-Won; Thanapprapasr, Duangmani; Dalton, Heather J; Pecot, Chad V; Rupaimoole, Rajesh; Lu, Chunhua; Fellman, Bryan; Urbauer, Diana; Kang, Yu; Jennings, Nicholas B; Huang, Li; Deavers, Michael T; Broaddus, Russell; Coleman, Robert L; Sood, Anil K.
  • Huang J; Authors' Affiliations: Departments of Gynecologic Oncology and Reproductive Medicine, Hematology and Oncology, Biostatistics, Cancer Biology, and Pathology, and The Center for RNA Interference and Non-Coding RNAs; The University of Texas MD Anderson Cancer Center, Houston, Texas.
Clin Cancer Res ; 20(7): 1846-55, 2014 Apr 01.
Article en En | MEDLINE | ID: mdl-24486585
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirimidinas / Tiazoles / Neoplasias Uterinas / Proteínas Proto-Oncogénicas c-raf / Receptor EphA2 / Proteínas Proto-Oncogénicas B-raf Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirimidinas / Tiazoles / Neoplasias Uterinas / Proteínas Proto-Oncogénicas c-raf / Receptor EphA2 / Proteínas Proto-Oncogénicas B-raf Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Año: 2014 Tipo del documento: Article